101 results
NT 10-K
q67mgt4 o6yo
28 Feb 24
Notice of late annual filing
5:01pm
8-K/A
EX-99.4
rt6fk7op fal1
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
EX-2.1
tpv30jah8avh5osvqmv
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
r66wi6znlg
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.2
a77n o7dpazuzvhng
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
ieujt2 efegtekfvqbn
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm